Larimar Therapeutics (LRMR) Cash & Current Investments (2013 - 2026)
Larimar Therapeutics' Cash & Current Investments came in at $156.27 million for Q2 2026, up 12.8% from $138.52 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Cash & Current Investments was $136.85 million, down 25.4% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $183.45 million in FY2024 (+111.4%), $86.79 million in FY2023 (-26.7%), $118.43 million in FY2022 (+68.9%) and $70.1 million in FY2021 (-24.3%).
- The five-year range for quarterly Cash & Current Investments is $54.92 million (Q2 2022) to $227.3 million (Q1 2024).
- Year-over-year, Cash & Current Investments increased in three of the last seven quarters, with growth averaging 18.4%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 117.0%), and the weakest in Q2 2025 (a decline of 38.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Larimar Therapeutics | 307.49 Mn | -299.58 Mn | - | 156.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156.27 Mn |
| Dec 31, 2025 | 136.85 Mn |
| Sep 30, 2025 | 175.44 Mn |
| Jun 30, 2025 | 138.52 Mn |
| Mar 31, 2025 | 157.53 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Sep 30, 2024 | 203.71 Mn |
| Jun 30, 2024 | 226.06 Mn |
| Mar 31, 2024 | 227.30 Mn |
| Dec 31, 2023 | 86.79 Mn |
| Sep 30, 2023 | 95.59 Mn |
| Jun 30, 2023 | 104.20 Mn |
| Mar 31, 2023 | 111.52 Mn |
| Dec 31, 2022 | 118.43 Mn |
| Sep 30, 2022 | 124.70 Mn |
| Jun 30, 2022 | 54.92 Mn |
| Mar 31, 2022 | 62.56 Mn |
| Dec 31, 2021 | 70.10 Mn |
| Sep 30, 2021 | 78.02 Mn |
| Jun 30, 2021 | 70.63 Mn |
API Access
Larimar Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();